Skip to content

The Metabolic implication of the breast reduction

The metabolic implication of the breast reduction - MIOBR

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000042412
Enrollment
35
Registered
2020-11-11
Start date
2018-03-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The augmented risk biomarkers of obesity-related diseases decrease after weight loss with diet or surgical removal of adipose tissue in patients with increased fat storage. Since the breast consists of mainly fat tissue, breast reduction surgery can lessen these augmented levels.

Interventions

Breast reduction surgery Control was 6 months later

Sponsors

Celal Bayar University, School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Women who requested breast reduction surgery. Each patient had breast hypertrophy with a distance between suprasternal notch and nipple greater than 28cm

Exclusion criteria

Exclusion criteria: Exclusion criteria were cardiovascular diseases, metabolic diseases such as diabetes and Cushing disease, connective tissue diseases, liver diseases, and endocrine disorders.

Design outcomes

Primary

MeasureTime frame
Preoperative and six months after surgery the levels of fasting blood glucose, insulin, hemoglobinA1c, triglyceride, total cholesterol, low-density lipoprotein, high-density lipoprotein, small dense low-density lipoprotein, macrophage chemotactic protein-1, adiponectin, lipoprotein-associated phospholipase A2, pentraxin-3, chemerin, interferon-gamma, interleukin-6, tumor necrosis factor-alfa, and highly sensitive C reactive protein were compared using Wilcoxon sign test.

Secondary

MeasureTime frame
Spearman correlation was used to investigate any relationship between the magnitudes of changes of the laboratory values and body mass index scores, and the amount of removed breast tissue.

Countries

Asia(except Japan)

Contacts

Public ContactYavuz Kececi

Celal Bayar University Plastic and Reconstructive Surgery

yavuz.kececi@gmail.com905323825901

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026